As of Feb 27
| +0.01 / +2.39%|
The 1 analysts offering 12-month price forecasts for CytRx Corp have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +834.58% increase from the last price of 0.43.
The current consensus among 1 polled investment analysts is to Buy stock in CytRx Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.